Latest News about MRNA
Recent news which mentions MRNA
Moderna Posts Quarterly Profit Despite Lower Sales From COVID-19 Vaccine
February 22, 2024
From Benzinga
Nasdaq, S&P 500 Futures Jump As Nvidia Surge Raises 'FOMO' Rally Hopes: Analyst Tells Why Jobs Data Holds Key For Momentum
February 22, 2024
From Benzinga
Earnings Scheduled For February 22, 2024
February 22, 2024
From Benzinga
Moderna Likely To Report Q4 Loss; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts
February 22, 2024
From Benzinga
Moderna Stock Q4 Earnings Preview: RSV mRNA Vaccine Scrutiny, Diminishing Spikevax Revenue, FDA Approval In Focus
February 21, 2024
From Benzinga
Looming Layoffs? 3 Companies That May Be the Next to Drop the Axe.
February 19, 2024
From InvestorPlace
10 Health Care Stocks Whale Activity In Today's Session
February 19, 2024
From Benzinga
To Sell or Not to Sell: How to Handle the Inevitable Nvidia Downturn
February 15, 2024
From InvestorPlace
Moderna's Options: A Look at What the Big Money is Thinking
February 14, 2024
Tickers
MRNA
From Benzinga
From InvestorPlace
2 Stocks Down 36% or More to Buy and Hold for 10 Years
February 13, 2024
From Motley Fool
3 Gene Editing Stocks With Unprecedented Surge Potential
February 13, 2024
From InvestorPlace
10 Health Care Stocks Whale Activity In Today's Session
February 12, 2024
From Benzinga
From Benzinga
3 Doomed Biotech Stocks to Dump Before They Dive: February 2024
February 11, 2024
From InvestorPlace
Why Is Moderna Stock Trading Lower Today?
February 09, 2024
From Benzinga
Spotlight on Moderna: Analyzing the Surge in Options Activity
February 09, 2024
Tickers
MRNA
From Benzinga
7 Stocks to Sell as Fast as You Possibly Can
February 08, 2024
Tags
MRNA
NASDAQ:APPS,NASDAQ:BOXL,NASDAQ:EL,NASDAQ:LUMN,NASDAQ:MRNA,NASDAQ:PENN,NASDAQ:WOOF
Stocks to Sell
From InvestorPlace
Tickers
MRNA
From Motley Fool
From Benzinga
3 Doomed Nasdaq Stocks to Dump Before They Dive: February 2024
February 05, 2024
From InvestorPlace
Biden Administration To Send Pharma Companies Opening Offers For Medicare Program's First Ever Drug Price Negotiations
February 02, 2024
From Benzinga
Pfizer Surprises With Profit But Revolutionizing Cancer Treatment Is Its Best Chance Of Getting Back In The Saddle
February 01, 2024
From Benzinga
Medicare's Historic Negotiations To Lower Drug Prices, Analysts Anticipate Upto Potential Price Cuts Of 60%
January 30, 2024
From Benzinga
1 Reason to Buy Novavax Stock Hand Over Fist and 1 Reason to Sell
January 28, 2024
From Motley Fool
My Top-5 AI Growth Stocks to Buy Hand Over Fist for 2024
January 27, 2024
From Motley Fool
1 Growth Stock Down 79% That's a Screaming Buy Right Now, According to Several Wall Street Analysts
January 26, 2024
Tickers
MRNA
From Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.